- IP hearings this week
- IP trials
- IP Judicial review hearings
- IP appeals at the Federal Court of Appeal
(As published on the Federal Court and Federal Court of Appeal websites on May 15, 2026)
This week in IP
| Date | File No. | Type | Name | Location | Length |
| May 19, 2026 | T-1957-22 | M | 1895784 Alberta Ltd. Operating As Hydrotec V. Faultless Solutions Corporation (Patent) | Ottawa | 1 d |
| May 19, 2026 | T-1594-26 | CMC | Abcellera Biologics Inc. V. Immvivos Pharmaceuticals Inc. (Patent) | Toronto | 1 h |
| May 19, 2026 | T-7-25 | TMC | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada (Patent - Apalutamide*) | Toronto | 1 h |
| May 19, 2026 | T-8-25 | TMC | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada Inc. (Patent - Apalutamide*) | Toronto | 1 h |
| May 19, 2026 | T-9-25 | TMC | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada Inc. (Patent - Apalutamide*) | Toronto | 1 h |
| May 20, 2026 | T-5200-25 | CMC | Astrazeneca Canada Inc. Et Al. V. Zydus Lifesciences Limited (Patent - Olaparib*) | Toronto | 30 m |
| May 20, 2026 | T-2504-25 | M | Novartis Pharmaceuticals Canada Inc Et Al. V. Apotex Inc. (Patent) | Ottawa | 1 d |
| May 20, 2026 | T-2505-25 | M | Novartis Pharmaceuticals Canada Inc Et Al. V. Apotex Inc. (Patent - Trametinib*) | Ottawa | 1 d |
| May 21, 2026 | T-2504-25 | CMC | Novartis Pharmaceuticals Canada Inc Et Al. V. Apotex Inc. (Patent) | Toronto | 1 h |
| May 21, 2026 | T-2505-25 | CMC | Novartis Pharmaceuticals Canada Inc Et Al. V. Apotex Inc. (Patent - Trametinib*) | Toronto | 1 h |
| May 21, 2026 | T-2593-24 | M | Janssen Inc. Et Al. V. Pharmascience Inc. (Patent - Macitentan*) | Toronto | 3 h |
| May 21, 2026 | T-3743-25 | CMC | Northern Reflections Ltd. V. Aritzia Inc. Et Al. (Trade Mark) | Ottawa | 1 h |
Return to top.
Scheduled IP Trials
| Date | File No. | Name | Location | Length |
| Aug 17, 2026 | T-7-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada (Patent - Apalutamide*) | Toronto | 4 d |
| Aug 17, 2026 | T-8-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada Inc. (Patent - Apalutamide*) | Toronto | 4 d |
| Aug 17, 2026 | T-9-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada Inc. (Patent - Apalutamide*) | Toronto | 4 d |
| Aug 24, 2026 | T-8-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada Inc. (Patent - Apalutamide*) | Toronto | 4 d |
| Aug 24, 2026 | T-9-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada Inc. (Patent - Apalutamide*) | Toronto | 4 d |
| Aug 24, 2026 | T-7-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada (Patent - Apalutamide*) | Toronto | 4 d |
| Aug 31, 2026 | T-7-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada (Patent - Apalutamide*) | Toronto | 4 d |
| Aug 31, 2026 | T-8-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada Inc. (Patent - Apalutamide*) | Toronto | 4 d |
| Aug 31, 2026 | T-9-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada Inc. (Patent - Apalutamide*) | Toronto | 4 d |
| Sep 8, 2026 | T-1142-18 | Navtech Inc. V. Chantier Davie Canada Inc. (unknown) | Québec | 4 d |
| Sep 8, 2026 | T-7-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada (Patent - Apalutamide*) | Toronto | 3 d |
| Sep 8, 2026 | T-8-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada Inc. (Patent - Apalutamide*) | Toronto | 3 d |
| Sep 8, 2026 | T-9-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada Inc. (Patent - Apalutamide*) | Toronto | 3 d |
| Sep 8, 2026 | T-75-25 | Boehringer Ingelheim(canada) Ltd. Et Al V.laboratoire Riva Inc (Patent - Empagliflozin*) | Toronto | 4 d |
| Sep 14, 2026 | T-75-25 | Boehringer Ingelheim(canada) Ltd. Et Al V.laboratoire Riva Inc (Patent - Empagliflozin*) | Toronto | 4 d |
| Sep 14, 2026 | T-1567-24 | Justin Stitches Inc. V. Makers Holdings Inc. (Trade Mark) | Vancouver | 5 d |
| Sep 16, 2026 | T-1142-18 | Navtech Inc. V. Chantier Davie Canada Inc. (unknown) | Québec | 2 d |
| Sep 21, 2026 | T-75-25 | Boehringer Ingelheim(canada) Ltd. Et Al V.laboratoire Riva Inc (Patent - Empagliflozin*) | Toronto | 4 d |
| Sep 28, 2026 | T-75-25 | Boehringer Ingelheim(canada) Ltd. Et Al V.laboratoire Riva Inc (Patent - Empagliflozin*) | Toronto | 2 d |
| Oct 19, 2026 | T-1059-22 | Seylynn (north Shore) Development Limited Partnership V. Denna Homes Group (Trade Mark) | Vancouver | 10 d |
| Oct 19, 2026 | T-451-20 | Kobold Corporation Et Al. V. Ncs Multistage Inc. (Patent) | Calgary | 4 d |
| Oct 26, 2026 | T-451-20 | Kobold Corporation Et Al. V. Ncs Multistage Inc. (Patent) | Calgary | 4 d |
| Nov 4, 2026 | T-1059-22 | Seylynn (north Shore) Development Limited Partnership V. Denna Homes Group (Trade Mark) | Vancouver | 2 d |
| Nov 9, 2026 | T-2593-24 | Janssen Inc. Et Al. V. Pharmascience Inc. (Patent - Macitentan*) | Toronto | 2 d |
| Nov 12, 2026 | T-2593-24 | Janssen Inc. Et Al. V. Pharmascience Inc. (Patent - Macitentan*) | Toronto | 2 d |
| Nov 18, 2026 | T-451-20 | Kobold Corporation Et Al. V. Ncs Multistage Inc. (Patent) | Calgary | 2 d |
| Nov 23, 2026 | T-742-25 | Salix Pharmaceuticals, Inc. V. Sandoz Canada Inc. (Patent) | Toronto | 8 d |
| Nov 23, 2026 | T-1818-23 | The Bank Of Nova Scotia V. Invesco Canada Ltd. (Trade Mark) | Toronto | 5 d |
| Dec 2, 2026 | T-1818-23 | The Bank Of Nova Scotia V. Invesco Canada Ltd. (Trade Mark) | Toronto | 2 d |
| Dec 7, 2026 | T-742-25 | Salix Pharmaceuticals, Inc. V. Sandoz Canada Inc. (Patent) | Toronto | 2 d |
| Jan 18, 2027 | T-1792-21 | Tanja Porcnik V. Cato Institute Et Al. (Copyright) | Toronto | 4 d |
| Jan 25, 2027 | T-1792-21 | Tanja Porcnik V. Cato Institute Et Al. (Copyright) | Toronto | 4 d |
| Feb 3, 2027 | T-1792-21 | Tanja Porcnik V. Cato Institute Et Al. (Copyright) | Toronto | 2 d |
| Mar 10, 2027 | T-2504-25 | Novartis Pharmaceuticals Canada Inc Et Al. V. Apotex Inc. (Patent) | To be determined (TrialJA) | 10 d |
| Mar 10, 2027 | T-2505-25 | Novartis Pharmaceuticals Canada Inc Et Al. V. Apotex Inc. (Patent - Trametinib*) | To be determined (TrialJA) | 10 d |
| Mar 30, 2027 | T-2505-25 | Novartis Pharmaceuticals Canada Inc Et Al. V. Apotex Inc. (Patent - Trametinib*) | To be determined (TrialJA) | 2 d |
| Mar 30, 2027 | T-2504-25 | Novartis Pharmaceuticals Canada Inc Et Al. V. Apotex Inc. (Patent) | To be determined (TrialJA) | 2 d |
| Apr 19, 2027 | T-3096-25 | Astrazeneca Canada Inc. Et Al. V. Cipla Ltd. (Patent - Olaparib*) | To be determined (TrialJA) | 4 d |
| Apr 26, 2027 | T-3096-25 | Astrazeneca Canada Inc. Et Al. V. Cipla Ltd. (Patent - Olaparib*) | To be determined (TrialJA) | 4 d |
| May 10, 2027 | T-3096-25 | Astrazeneca Canada Inc. Et Al. V. Cipla Ltd. (Patent - Olaparib*) | To be determined (TrialJA) | 2 d |
| May 10, 2027 | T-3206-25 | Leo Pharma Inc. Et Al. V. Glenmark Pharmaceuticals Canada Inc. (Patent - Calcipotriol*) | Toronto | 4 d |
| May 17, 2027 | T-3206-25 | Leo Pharma Inc. Et Al. V. Glenmark Pharmaceuticals Canada Inc. (Patent - Calcipotriol*) | Toronto | 3 d |
| May 25, 2027 | T-3206-25 | Leo Pharma Inc. Et Al. V. Glenmark Pharmaceuticals Canada Inc. (Patent - Calcipotriol*) | Toronto | 2 d |
| Jun 22, 2027 | T-3922-25 | Astrazeneca Canada Inc. Et Al. V. Natco Pharma (canada) Inc. (Patent - Olaparib*) | Ottawa | 9 d |
| Jun 28, 2027 | T-3739-25 | Novartis Pharmaceuticals Canada Inc V. Pharmascience Inc. Et Al. (Patent - Ruxolitinib*) | To be determined (TrialJA) | 3 d |
| Jul 2, 2027 | T-3739-25 | Novartis Pharmaceuticals Canada Inc V. Pharmascience Inc. Et Al. (Patent - Ruxolitinib*) | To be determined (TrialJA) | 5 d |
| Jul 7, 2027 | T-3922-25 | Astrazeneca Canada Inc. Et Al. V. Natco Pharma (canada) Inc. (Patent - Olaparib*) | Ottawa | 2 d |
| Jul 15, 2027 | T-3739-25 | Novartis Pharmaceuticals Canada Inc V. Pharmascience Inc. Et Al. (Patent - Ruxolitinib*) | To be determined (TrialJA) | 2 d |
| Aug 9, 2027 | T-4459-25 | Novartis Pharmaceuticals Canada Inc. V. Dr. Reddy's Laboratories Ltd. Et Al. (Patent - Ruxolitinib*) | Ottawa | 10 d |
| Aug 9, 2027 | T-3962-25 | Knight Therapeutics Inc. Et Al. V. Taro Pharmaceuticals Inc. (Patent - Doxepin*) | Toronto | 4 d |
| Aug 16, 2027 | T-3962-25 | Knight Therapeutics Inc. Et Al. V. Taro Pharmaceuticals Inc. (Patent - Doxepin*) | Toronto | 4 d |
| Aug 26, 2027 | T-3962-25 | Knight Therapeutics Inc. Et Al. V. Taro Pharmaceuticals Inc. (Patent - Doxepin*) | Ottawa | 2 d |
| Aug 26, 2027 | T-4459-25 | Novartis Pharmaceuticals Canada Inc. V. Dr. Reddy's Laboratories Ltd. Et Al. (Patent - Ruxolitinib*) | Ottawa | 2 d |
| Sep 20, 2027 | T-78-26 | Novartis Pharmaceuticals Canada Inc. V. Teva Canada Limited Et Al. (Patent - Ruxolitinib*) | To be determined (TrialJA) | 10 d |
| Oct 7, 2027 | T-78-26 | Novartis Pharmaceuticals Canada Inc. V. Teva Canada Limited Et Al. (Patent - Ruxolitinib*) | To be determined (TrialJA) | 2 d |
| Oct 19, 2027 | T-846-26 | Novartis Pharmaceuticals Canada Inc. Et Al. V. Zydus Lifesciences Limited (Patent - Sacubitril*) | Ottawa | 8 d |
| Nov 8, 2027 | T-323-26 | Lundbeck Canada Inc. Et Al. V. Laboratoire Riva Inc. (Patent - Vortioxetine*) | To be determined (TrialJA) | 10 d |
| Nov 22, 2027 | T-1266-26 | Genentech, Inc. And Hoffmann-la Roche Limtited V. Biosimilar Collaborations Ireland Limited (Patent) | Toronto | 4 d |
| Nov 24, 2027 | T-323-26 | Lundbeck Canada Inc. Et Al. V. Laboratoire Riva Inc. (Patent - Vortioxetine*) | To be determined (TrialJA) | 2 d |
| Nov 29, 2027 | T-1266-26 | Genentech, Inc. And Hoffmann-la Roche Limtited V. Biosimilar Collaborations Ireland Limited (Patent) | Toronto | 4 d |
| Dec 7, 2027 | T-1266-26 | Genentech, Inc. And Hoffmann-la Roche Limtited V. Biosimilar Collaborations Ireland Limited (Patent) | Toronto | 2 d |
Return to top.
Scheduled Judicial Review Hearings
| Date | File No. | Name | Type | Location | Length |
| May 25, 2026 | T-165-25 | Mallinckrodt Hospital Products Inc. V. Agc | Others - Crown (v. Crown) [Applications] | Toronto | 1 d |
| May 26, 2026 | T-1160-24 | Martinizing International, Llc V. C&d Makridis Holdings Ltd. | Trade Mark Infringement | Toronto | 1 d |
| Jun 3, 2026 | T-4795-25 | Arista Records Llc And Al V. John Doe1 Dba Y2mate.ws....., And Al | Copyright Infringement [Applications] | Ottawa | 3 h |
| Jun 8, 2026 | T-1895-23 | Smart And Biggar Llp V. Ctc Brand Corp. | Trade Mark Infringement | Toronto | 1 d |
| Jun 9, 2026 | T-1758-22 | Remitbee Incorporated V. Remitly, Inc. | Trade Mark - Appeal of a decision of the Registrar | Vancouver | 2 d |
| Jun 9, 2026 | T-2621-23 | Remitbee Incorporated V. Remitly, Inc. | Trade Mark - Appeal of a decision of the Registrar | Vancouver | 2 d |
| Jun 11, 2026 | T-2380-25 | Beijing Pop Mart Cultural Creative Co. Ltd V. Ec New York (uk) Ltd | Trade Mark - Appeal of a decision of the Registrar | Montréal | 2.5 h |
| Jun 24, 2026 | T-3158-25 | Laurelle Downey V. Kehewin Cree Nation | S. 18.1 Application for Judicial Review (Aboriginal Law) | Edmonton | 1 d |
| Jul 2, 2026 | T-1879-25 | Rex International Food Inc. V. 9107-7438 Quebec Lnc. D.b.a Akhavan Food | S. 18.1 Application for Judicial Review | Ottawa | 2 h |
| Jul 21, 2026 | T-1728-26 | Janssen Inc. Et Al. V. Agc Et Al. | S. 18.1 Application for Judicial Review | Toronto | 1 d |
Return to top.
Scheduled IP Appeals
| Date | File No. | Name | Type | Location |
| May 27, 2026 | A-254-25 | Bell Canada Et Al. V. Copyright Collective Of Canada Et Al. | S.28 Copyright Board | Ottawa |
| May 28, 2026 | A-118-25 | Sea Tow Services International, Inc. V. C-tow Assistance Ltd | Appeal (S.27 - Final) - Others [from T-901-22 - Trade Mark - Appeal of a decision of the Registrar] | Ottawa |
| May 28, 2026 | A-117-25 | Sea Tow Services International, Inc. V. C-tow Marine Assistance Ltd | Appeal (S.27 - Final) - Others [from T-877-22 - Trade Mark Infringement] | Ottawa |
| May 28, 2026 | A-47-25 | Sea Tow Services International, Inc. V. C-tow Marine Assistance Ltd | Appeal (S.27 - Interloc.) - Others [from T-901-22 - Trade Mark - Appeal of a decision of the Registrar] | Ottawa |
| May 28, 2026 | A-48-25 | Sea Tow Services International Inc V. C-tow Marine Assistance Ltd | Appeal (S.27 - Interloc.) - Others [from T-877-22 - Trade Mark Infringement] | Ottawa |
| Jun 15, 2026 | A-232-25 | The Lounge Medical Spa Ltd. Et Al V. Dermaspark Products Inc. Et Al | Appeal (S.27 - Final) - Trade-marks Act | Edmonton |
| Jun 15, 2026 | A-278-25 | Roula Hamdan Et Al. V. Dermaspark Products Inc. Et Al. | Appeal (S.27 - Final) - Trade-marks Act | Edmonton |
* Medicinal ingredients are based on automated analysis and should not be relied upon.
Return to top.